Latest Articles
SGO 2025: Gaining Ground in the Treatment of Endometrial Cancer - Medscape
SGO 2025: Gaining Ground in the Treatment of Endometrial Cancer Medscape
Published: March 21, 2025, 7:05 p.m.
SGO 2025: Gaining Ground in Endometrial Cancer - Medscape
SGO 2025: Gaining Ground in Endometrial Cancer Medscape
Published: March 21, 2025, 7:05 p.m.
AI model detects endometrial cancer at almost 100 per cent accuracy - NT News
AI model detects endometrial cancer at almost 100 per cent accuracy NT News
Published: March 19, 2025, 3:45 p.m.
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı
Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı
Published: March 19, 2025, 2:55 p.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN
Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN
Published: March 19, 2025, 1:18 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today
Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today
Published: March 18, 2025, 8:07 p.m.
The Importance of Spotting Endometrial Cancer - Curetoday.com
The Importance of Spotting Endometrial Cancer Curetoday.com
Published: March 18, 2025, 3:24 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - oncologynewscentral.com
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups oncologynewscentral.com
Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!